Financhill
Back

UiPath, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison

Buy
57

PATH
UiPath, Inc.

Last Price:
$19.29
Seasonality Move:
-12.64%
Sell
50

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$68.58
Seasonality Move:
40.49%
Buy
57
UiPath, Inc. (PATH) is a Buy

Is UiPath, Inc. a Buy, Sell or Hold?

  • The current UiPath, Inc. [PATH] share price is $19.29. The Score for PATH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • PATH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath, Inc.'s stock price today?

  • The UiPath, Inc. share price today is $19.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PATH is experiencing slight buying pressure.

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals, Inc.'s stock price today?

  • The Arrowhead Pharmaceuticals, Inc. share price today is $68.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 78.3 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.91 - 16.27) Buy
Bollinger Bands (100): (11.13 - 15.45) Buy

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 75.92 Buy
Chaikin Money Flow: 249389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.15 - 56.87) Buy
Bollinger Bands (100): (20.01 - 44.73) Buy

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.9 Buy
20-day SMA: 14.58 Buy
50-day SMA: 15.04 Buy
200-day SMA: 12.63 Buy
8-day EMA: 16.62 Buy
20-day EMA: 15.34 Buy
50-day EMA: 14.62 Buy
200-day EMA: 13.45 Buy

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.55 Buy
20-day SMA: 48.94 Buy
50-day SMA: 42.23 Buy
200-day SMA: 23.8 Buy
8-day EMA: 60.08 Buy
20-day EMA: 52.14 Buy
50-day EMA: 43.49 Buy
200-day EMA: 29.21 Buy

UiPath, Inc. Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.01 per share, and an increase next year of $0.20 per share.

Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.

UiPath, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):